Laboratorios Silanes S.a. De C.v.
Clinical trials sponsored by Laboratorios Silanes S.a. De C.v., explained in plain language.
-
New combo pill aims to ease joint pain faster
Symptom relief CompletedThis study tested whether a combination of two drugs (etoricoxib and betamethasone) works better than etoricoxib alone for reducing pain in people with sudden joint inflammation (bursitis, tendinitis, or synovitis) in the shoulder, elbow, knee, or ankle. About 89 adults took part…
Phase: PHASE3 • Sponsor: Laboratorios Silanes S.A. de C.V. • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
New combo pill shows promise for back pain sufferers
Symptom relief CompletedThis study tested whether a fixed-dose combination of two drugs (etoricoxib and tizanidine) works better than etoricoxib alone for acute low back pain with muscle spasms. 136 adults with moderate to severe pain took part. Researchers measured pain changes over 7 days and tracked …
Phase: PHASE3 • Sponsor: Laboratorios Silanes S.A. de C.V. • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC
-
New combo pill tested in healthy volunteers to see how it stacks up against separate drugs
Knowledge-focused CompletedThis study tested a new tablet that combines two drugs (etoricoxib and betamethasone) in healthy adults to see if the body absorbs it the same as taking each drug separately. Forty-two participants received single doses of the combo tablet, the etoricoxib tablet alone, and betame…
Phase: PHASE1 • Sponsor: Laboratorios Silanes S.A. de C.V. • Aim: Knowledge-focused
Last updated May 17, 2026 13:53 UTC
-
Heart pill combo tested in healthy volunteers
Knowledge-focused CompletedThis study tested whether a single pill containing two heart medications (ticagrelor and aspirin) works the same as taking them separately. Twenty-four healthy adults took both forms and had their blood levels measured. The goal was to see if the combination pill is absorbed simi…
Phase: PHASE1 • Sponsor: Laboratorios Silanes S.A. de C.V. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC